ATE556717T1 - Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus - Google Patents
Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirusInfo
- Publication number
- ATE556717T1 ATE556717T1 AT10151641T AT10151641T ATE556717T1 AT E556717 T1 ATE556717 T1 AT E556717T1 AT 10151641 T AT10151641 T AT 10151641T AT 10151641 T AT10151641 T AT 10151641T AT E556717 T1 ATE556717 T1 AT E556717T1
- Authority
- AT
- Austria
- Prior art keywords
- sars
- cov
- acute respiratory
- respiratory syndrome
- severe acute
- Prior art date
Links
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 title abstract 5
- 241000711573 Coronaviridae Species 0.000 title abstract 2
- 238000006386 neutralization reaction Methods 0.000 title 1
- 229940096437 Protein S Drugs 0.000 abstract 1
- 101000629313 Severe acute respiratory syndrome coronavirus Spike glycoprotein Proteins 0.000 abstract 1
- 101710198474 Spike protein Proteins 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 229940124452 immunizing agent Drugs 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000001024 immunotherapeutic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1002—Coronaviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65104605P | 2005-02-08 | 2005-02-08 | |
| US14192505A | 2005-05-31 | 2005-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE556717T1 true ATE556717T1 (de) | 2012-05-15 |
Family
ID=36793717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT10151641T ATE556717T1 (de) | 2005-02-08 | 2006-02-08 | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1855719A4 (de) |
| JP (1) | JP2008529504A (de) |
| AT (1) | ATE556717T1 (de) |
| AU (1) | AU2006213775C1 (de) |
| BR (1) | BRPI0606148A2 (de) |
| CA (1) | CA2595780A1 (de) |
| ES (1) | ES2384497T3 (de) |
| MX (1) | MX2007009512A (de) |
| NZ (1) | NZ560328A (de) |
| WO (1) | WO2006086561A2 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170018920A (ko) | 2014-06-12 | 2017-02-20 | 우니베르시다데 도 포르토 - 레이토리아 | 면역약화된 숙주용 백신 |
| CN113292650B (zh) * | 2020-02-24 | 2022-08-12 | 中国科学院微生物研究所 | 新型冠状病毒的人源单克隆抗体及其应用 |
| CN113292649B (zh) * | 2020-02-24 | 2022-08-12 | 中国科学院微生物研究所 | 新型冠状病毒的人源单克隆抗体及其应用 |
| CN113391064A (zh) * | 2020-03-13 | 2021-09-14 | 科美诊断技术股份有限公司 | 用于检测新型冠状病毒中和抗体的受体试剂及其应用 |
| CN111560074B (zh) * | 2020-03-20 | 2021-07-09 | 中山大学 | 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白单区域亚单位纳米疫苗 |
| CN111983226A (zh) | 2020-03-25 | 2020-11-24 | 新加坡国立大学 | SARSr-CoV抗体的检测 |
| WO2021202893A1 (en) * | 2020-04-03 | 2021-10-07 | Nonigenex, Inc. | Detecting adaptive immunity to coronavirus |
| WO2021221137A1 (ja) * | 2020-05-01 | 2021-11-04 | 花王株式会社 | 抗ＳＡＲＳ－ＣｏＶ－２抗体を用いた医薬品及び検査キット |
| CN111995676B (zh) * | 2020-05-15 | 2021-03-09 | 潍坊医学院 | 一种针对新冠病毒棘突蛋白非rbd区的单克隆抗体及其应用 |
| WO2021238910A1 (en) * | 2020-05-25 | 2021-12-02 | Guo Bingshi | Anti-coronavirus spike protein antibodies and uses thereof |
| CN112017782A (zh) * | 2020-06-01 | 2020-12-01 | 北京松果天目健康管理有限公司 | SARS-CoV-2易感性的检测方法及新冠病毒重症风险预测方法 |
| CA3179834A1 (en) * | 2020-06-25 | 2021-12-30 | David S. Block | Ace2-fc fusion proteins and methods of use |
| US20240051993A1 (en) | 2020-07-16 | 2024-02-15 | Caregen Co, Ltd. | Peptide with neutralizing activity against severe acute respiratory syndrome coronavirus 2 |
| CN113945714B (zh) * | 2020-07-16 | 2023-01-31 | 南京蓬勃生物科技有限公司 | 新型冠状病毒中和抗体类药物中和能力的检测方法 |
| CN112010984B (zh) * | 2020-08-04 | 2021-10-12 | 广州千扬生物医药技术有限公司 | 一种基于幽门螺旋杆菌铁蛋白的新型冠状病毒s蛋白多聚体纳米疫苗 |
| US20230312689A1 (en) | 2020-08-26 | 2023-10-05 | National University Corporation Kumamoto University | Human antibody or antigen-binding fragment thereof against coronavirus spike protein |
| CN114181301B (zh) * | 2020-09-14 | 2023-04-28 | 复旦大学 | 针对SARS-CoV-2的无ADE效应的中和抗体 |
| CN113156129B (zh) * | 2021-01-13 | 2022-04-05 | 广东菲鹏生物有限公司 | 中和抗体高敏检测方法及产品 |
| WO2022161346A1 (en) * | 2021-01-27 | 2022-08-04 | Bioduro (Jiangsu) Co., Ltd. | Antibody against sars-cov-2 |
| CN115109150B (zh) * | 2021-01-31 | 2024-06-25 | 中南大学湘雅医院 | 新型冠状病毒单克隆抗体xy10及其应用 |
| CN116973566A (zh) * | 2021-02-03 | 2023-10-31 | 广东菲鹏生物有限公司 | 一种鉴别结合突变型抗原的抗体的方法及试剂 |
| EP4089112A1 (de) * | 2021-05-14 | 2022-11-16 | Ustav organicke chemie a biochemie AV CR, v.v.i. | Antikörper mit bindung an rbd des spike-proteins von sars-cov-2 und verfahren zur quantifizierung von schützenden antikörpern gegen sars-cov-2 |
| WO2023148641A1 (en) * | 2022-02-02 | 2023-08-10 | Translational Health Science And Technology Institute | Monoclonal antibodies specific to receptor binding domain of sars-cov2 and uses thereof |
-
2006
- 2006-02-08 EP EP06720569A patent/EP1855719A4/de not_active Withdrawn
- 2006-02-08 AT AT10151641T patent/ATE556717T1/de active
- 2006-02-08 ES ES10151641T patent/ES2384497T3/es active Active
- 2006-02-08 BR BRPI0606148-6A patent/BRPI0606148A2/pt not_active Application Discontinuation
- 2006-02-08 JP JP2007554351A patent/JP2008529504A/ja active Pending
- 2006-02-08 CA CA002595780A patent/CA2595780A1/en not_active Abandoned
- 2006-02-08 AU AU2006213775A patent/AU2006213775C1/en not_active Ceased
- 2006-02-08 NZ NZ560328A patent/NZ560328A/en not_active IP Right Cessation
- 2006-02-08 WO PCT/US2006/004599 patent/WO2006086561A2/en active Application Filing
- 2006-02-08 MX MX2007009512A patent/MX2007009512A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ560328A (en) | 2010-05-28 |
| AU2006213775B2 (en) | 2010-11-11 |
| AU2006213775A1 (en) | 2006-08-17 |
| WO2006086561A2 (en) | 2006-08-17 |
| JP2008529504A (ja) | 2008-08-07 |
| BRPI0606148A2 (pt) | 2009-06-02 |
| AU2006213775C1 (en) | 2011-11-03 |
| WO2006086561A3 (en) | 2009-04-23 |
| MX2007009512A (es) | 2008-02-21 |
| ES2384497T3 (es) | 2012-07-05 |
| EP1855719A4 (de) | 2009-11-04 |
| CA2595780A1 (en) | 2006-08-17 |
| EP1855719A2 (de) | 2007-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE556717T1 (de) | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus | |
| UA109633C2 (uk) | Антитіло людини проти тканинного фактора | |
| EA200970469A1 (ru) | Антитела-агонисты рецептора trkb и их применение | |
| CR8698A (es) | Anticuerpos monoclonales al factor de crecimiento de hepatocito | |
| NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
| AR057807A1 (es) | Formulaciones de anticuerpo anti-cd3 | |
| ATE517922T1 (de) | Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation | |
| RU2009148286A (ru) | Жидкая фармацевтическая композиция ботулинического токсина | |
| CY1115935T1 (el) | Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| BR0314038A (pt) | Anticorpo humano isolado, método de tratar uma doença mediada com il-1 em um paciente, composição farmacêutica, cadeias pesada e leve, e, método de mapeamento de epitopo de um antìgeno selecionado | |
| EA200801071A1 (ru) | Способы и композиции для применения в целях лечения пациентов с положительным по аутоантителам заболеванием | |
| CY1111193T1 (el) | Ανθρωπινα cdr-μοσχευμενα αντισωματα και θραυσματα αντισωματων τους | |
| BR112012001984B8 (pt) | anticorpos humanos com alta afinidade para angiopoietina-2 humana, uso dos mesmos e composição farmacêutica | |
| ATE412179T1 (de) | Nachweis von arzneistoffen der methamphetamingruppe | |
| TW200740840A (en) | Diagnostic test kits | |
| WO2005012337A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
| ATE497774T1 (de) | Screening kombinatorischer proteinbibliotheken mittels periplasmatischer expression | |
| WO2004111081A3 (en) | Antigenic peptides of sars coronavirus and uses thereof | |
| EA200700345A1 (ru) | Обогащённое антитело для выявления микобактериальной инфекции, способы применения и диагностические тесты, применяющие такое антитело | |
| UA105760C2 (uk) | Антитіло проти bst2 | |
| 이동규 et al. | The N-terminal region of the porcine epidemic diarrhea virus spike protein is important for the receptor binding | |
| WO2010031749A9 (en) | Compositions and methods for detecting tlr3 | |
| WO2009070507A3 (en) | Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma | |
| DK1869185T3 (da) | Konjugat med P21-protein til kræftbehandling | |
| WO2012051372A3 (en) | Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |